Abstract
Production and handling of manufactured nanoparticles (MNP) may result in unwanted worker exposure. The size distribution and structure of MNP in the breathing zone of workers will differ from the primary MNP produced. Homogeneous coagulation, scavenging by background aerosols, and surface deposition losses are determinants of this change during transport from source to the breathing zone, and to a degree depending on the relative time scale of these processes. Modeling and experimental studies suggest that in MNP production scenarios, workers are most likely exposed to MNP agglomerates or MNP attached to other particles. Surfaces can become contaminated by MNP, which constitute potential secondary sources of airborne MNP-containing particles. Dustiness testing can provide insight into the state of agglomeration of particles released during handling of bulk MNP powder. Test results, supported by field data, suggest that the particles released from powder handling occur in distinct size modes and that the smallest mode can be expected to have a geometric mean diameter >100 nm. The dominating presence of MNP agglomerates or MNP attached to background particles in the air during production and use of MNP implies that size alone cannot, in general, be used to demonstrate presence or absence of MNP in the breathing zone of workers. The entire respirable size fraction should be assessed for risk from inhalation exposure to MNP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.